| 51st week of 2010 patent applcation highlights part 40 |
| Patent application number | Title | Published |
|---|
| 20100322996 | Fluid Absorbent Adhesive Articles - A fluid absorbing pressure sensitive adhesive composition and adhesive articles including the fluid absorbing adhesive that have particular utility in the medical field, and in particular, for use with wound dressings is provided. The adhesive composition has superior fluid handling capacity, moisture vapor transmission and skin adhesion. | 2010-12-23 |
| 20100322997 | METHOD FOR PRODUCING BIOLOGICALLY INGESTIBLE MICROPARTICLES, BIOLOGICALLY INGESTIBLE MICROPARTICLES, AND DISPERSION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - A method of separating biologically ingestible microparticles is used to obtain biologically ingestible microparticles in a thin film fluid formed between two processing surfaces provided with a solution containing a first solvent in which an objective substance to be pulverized is dissolved and a solvent capable of serving as a second solvent in which the solubility of the microparticles is lower than in the first solvent, the two processing surfaces being arranged so as to be able to approach to and separate from each other, at least one of which rotates relative to the other. | 2010-12-23 |
| 20100322998 | SKIN ULCER PREVENTIVE CURATIVE AGENT CONTAINING HUMAN RECOMBINANT HGF - A neovascularization promoting composition, a granulation formation-promoting composition and a preventive or curative composition for skin ulcer, comprising a human recombinant HGF wherein five amino acid residues are deleted in the first Kringle domain thereof. The provided compositions of the present invention are useful as a drug capable of promoting granulation formation and neovascularization and being effective in tissue restoration, especially as a preventive and curative agent for skin ulcer. | 2010-12-23 |
| 20100322999 | FENTANYL-CONTAINING PATCH FOR EXTERNAL USE - A patch for external use which has a laminate structure comprising a substrate and a pressure-sensitive adhesive layer which contains a styrene/isoprene/styrene block copolymer as the base and further contains a tackifier resin consisting of a rosin resin and at least one other tackifier resin, a softening agent consisting of polybutene and liquid paraffin, a fatty acid ester, and fentanyl, characterized in that the weight ratio of the rosin resin to fentanyl is 1 to 5, the weight ratio of the rosin resin to the whole tackifier resin is 0.1 to 0.6, and the tackifier resin accounts for 30 to 60wt % of the whole pressure-sensitive adhesive layer. The patch is excellent in the permeation of fentanyl through the skin and in storage stability, and is weak in irritation to skin. | 2010-12-23 |
| 20100323000 | METHOD AND PROCESS FOR PREPARING CARDIOLIPIN - The invention provides novel methods for preparing cardiolipin and cardiolipin analogs having varying fatty acid chain lengths, particularly 1,1′,2,2′-tetramyristoyl cardiolipin. The methods comprise reacting a starting compound, such as a 1,2-O-sn-diacylglycerol and a 2-protected glycerol, with a phosphoramidite reagent to produce a protected cardiolipin, which is deprotected to prepare cardiolipin. The cardiolipin and cardiolipin analogs may be prepared in the presence of an activator, such as pyridinium trifluororacetate. The methods of the present invention are used to prepare cardiolipin and cardiolipin analogs in large quantities. The cardiolipin prepared by the present methods can be incorporated into liposomes which can also include active agents such as hydrophobic or hydrophilic drugs. Such liposomes can be used to treat diseases or in diagnostic and/or analytical assays. | 2010-12-23 |
| 20100323001 | In Vivo Delivery Of Double Stranded RNA To a Target Cell - The invention encompasses methods of delivering nucleic acids, including dsRNA, to mammalian target cells in vivo via intercellular transfer, wherein the dsRNA is delivered to or expressed in a first cell different from the target cell, wherein the first cell facilitates delivery of the dsRNA to the target cell. | 2010-12-23 |
| 20100323002 | INHIBITION OF MELANOGENESIS AND MELANOMA METASTASIS WITH P-AMINO BENZOIC ACID (PABA) - The present invention relates to the inhibition of melanogenesis with para-aminobenzoic acid (PABA) and its use in treating melanotic cancer. | 2010-12-23 |
| 20100323003 | Flaviviridae Mutants Comprising a Deletion in the Capsid Protein for Use as Vaccines - The present invention relates to a mutant virus of the family flaviviridae, comprising a deletion in the capsid protein of at least 20 successive amino acids, without any further deletion, substitution or insertion mutation except of the amino acids next to the deletion, which may be substituted. | 2010-12-23 |
| 20100323004 | NON-PEGYLATED LIPOSOMAL DOXORUBICIN TRIPLE COMBINATION THERAPY - The present invention relates to a method for treating metastatic breast cancer in an individual comprising administering to an individual in need thereof a dosing regimen which comprises administering to the individual nonpegylated liposomal doxorubicin, a taxane and a HER2/neu receptor antagonist, wherein the individual previously has been administered an anthracycline. | 2010-12-23 |
| 20100323005 | Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen - Sodium ibuprofen compositions and methods of manufacturing tablets and caplets comprising sodium ibuprofen are described. The formulation is advantageous because it allows for the formation of tablets having low sodium content and further provides tablets exhibiting improved physical stability, high tablet hardness and high strength, coupled with excellent dissolution and bioavailability characteristics. The formulations and processes are further advantageous because they can be produced in large quantities without an unacceptable number of defective tablets. | 2010-12-23 |
| 20100323006 | PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF - The subject invention provides a novel pharmaceutical solid preparation that has superior disintegration properties and excellent solubility, leading to sufficient absorbability of active ingredients through the gastrointestinal tract. The pharmaceutical solid preparation of the present invention comprises:
| 2010-12-23 |
| 20100323007 | A POLYAMIDE RATE-MODULATED MONOLITHIC DRUG DELIVERY SYSTEM - This invention relates to a polyamide rate-modulated monolithic drug delivery system comprising at least one active compound and a biodegradable and biocompatible polyamide polymer. The polymer is selected for delivering, in use, the active compound, within a predetermined time frame depending on the biodegradable properties of the polymer, to a target organism or organisms. In one embodiment of the invention the polymer is modified by salting-out or crosslinking the polymeric material to achieve the desired biodegradability characteristics and, consequently, to control the release of the active compound. | 2010-12-23 |
| 20100323008 | SOLID DOSAGE FORM COMPRISING A FIBRATE - The invention provides stable, solid dosage forms and pharmaceutical compositions in particulate form comprising a fibrate, for example fenofibrate, dissolved in an non-aqueous vehicle in order to ensure improved bioavailability of the active ingredient upon oral administration relative to known fibrate formulations. | 2010-12-23 |
| 20100323009 | Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications - A solid composition in the form of a tablet that generates and releases a biocidal solution comprising at least chlorine dioxide with an enhanced weight percent yield is presented. The composition comprises reactants capable of in-situ generation of chlorine dioxide comprising a chlorite donor that is coated with a gel-forming material that slows the rate of dissolution of the high solubility chlorite donor, a free halogen donor, and an acid source, resulting in an unexpectedly high weight percent yield and providing a controlled release of biocidal solution. The compositions of the invention show improved environmental stability which can reduce the cost of packaging and significantly increase the utility of the composition. The controlled release allows the use in multi-tablet chemical dispensers which may otherwise induce potentially explosive conditions or allow rapid release of the biocidal solution thereby inducing a spike in chemical concentration rather than a controlled and sustained release. | 2010-12-23 |
| 20100323010 | FORMULATION AND PROCESS FOR DRUG LOADED CORES - The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core. | 2010-12-23 |
| 20100323011 | PHARMACEUTICAL COMPOSITIONS OF A COMBINATION OF METFORMIN AND A DIPEPTIDYL PEPTIDASE-IV INHIBITOR - Disclosed are pharmaceutical compositions comprising fixed-dose combinations of an extended-release form of metformin, or a pharmaceutically acceptable salt thereof, coated with an immediate-release form of the DPP-4 inhibitor sitagliptin, or a pharmaceutically acceptable salt thereof. | 2010-12-23 |
| 20100323012 | Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and Diuretics - A novel combination therapy for cardiovascular diseases or conditions, including administering a synergistic combination of at least one inhibitor of neutral endopeptidase, at least one inhibitor of the endogenous endothelin producing system and at least one diuretic, preferably a thiazide diuretic or an adenosine A1 antagonist. | 2010-12-23 |
| 20100323013 | HYDROLYSATES MADE OF PLANT EXTRACTS AND ANTIBACTERIAL AGENT CONTAINING THE SAME - The present invention relates to an antibacterial agent and a hydrolysate made of at least one extract that has been produced by extraction using ethanol/water from dried plant material of: a) at least one of the plants selected from the group consisting of: | 2010-12-23 |
| 20100323014 | NANOPARTICLES COMPRISING A NON-IONIZABLE CELLULOSIC POLYMER AND AN AMPHIPHILIC NON-IONIZABLE BLOCK COPOLYMER - A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug, a poorly aqueous soluble non-ionizable cellulosic polymer, and a poorly aqueous soluble polymeric amphiphilic non-ionizable block copolymer. | 2010-12-23 |
| 20100323015 | MODIFIED RELEASE FORMULATION AND METHODS OF USE - A modified release pharmaceutical formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl) carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate or hydrate thereof, about 5-30% of a drug delivery matrix including hydroxypropylmethylcellulose (HPMC), and an enteric polymer. The pharmaceutical formulation produces a sustained plasma concentration of retigabine following administration to a subject for 4-20 hours longer than the time required for in vitro release of 80% of retigabine. The plasma concentration vs. time profile of this formulation is substantially flat over an extended period lasting for about 4 hours to about 36 hours. A method of treating a disorder characterized by nervous system hyperexcitability includes administering to a subject an effective amount of these pharmaceutical formulations. | 2010-12-23 |
| 20100323016 | MODIFIED RELEASE FORMULATION AND METHODS OF USE - A modified release pharmaceutical formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate or hydrate thereof, about 5-30% of a drug delivery matrix including hydroxypropylmethylcellulose (HPMC), and an enteric polymer. The pharmaceutical formulation produces a sustained plasma concentration of retigabine following administration to a subject for 4-20 hours longer than the time required for in vitro release of 80% of retigabine. The plasma concentration vs. time profile of this formulation is substantially flat over an extended period lasting for about 4 hours to about 36 hours. A method of treating a disorder characterized by nervous system hyperexcitability includes administering to a subject an effective amount of these pharmaceutical formulations. | 2010-12-23 |
| 20100323017 | Escitalopram and Solid Pharmaceutical Composition Comprising the Same - The present invention relates to Escitalopram having a small median particle size and a solid pharmaceutical composition comprising the same. | 2010-12-23 |
| 20100323018 | Branched DNA/RNA monomers and uses thereof - The invention provides compositions and methods relating to delivery of agents in vivo or in vitro. More specifically, the invention provides nanoparticles synthesized from crosslinked nucleic acids, optionally having a lipid shell or coating, and may further comprise for example small molecule or high molecular weight compounds as therapeutic or diagnostic agents. | 2010-12-23 |
| 20100323019 | Microparticles for the treatment of disease - Microparticle-bioactive agent based treatments for local treatment of diseased tissues/organs are disclosed. | 2010-12-23 |
| 20100323020 | STABLE NANOPARTICULATE DRUG SUSPENSION - A liquid pharmaceutical composition comprises an aqueous medium having suspended therein a solid particulate Bc1-2 family protein inhibitory compound such as ABT-263, having a D | 2010-12-23 |
| 20100323021 | ANTITUMORAL TREATMENTS - The present invention relates to colloidal metal nanoparticles conjugated with Kahalalide F, or an analogue thereof, and their use in the treatment of cancer. The invention also relates to a method for increasing the antitumoral activity of Kahalalide F, or an analogue thereof, which comprises conjugating the Kahalalide F, on an analogue thereof, with a colloidal metal nanoparticle. | 2010-12-23 |
| 20100323022 | CALCIUM PHOSPHATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF - A calcium phosphate composition comprising calcium phosphate particles (A) and a sulfonic acid salt (B), wherein the calcium phosphate composition contains 0.5 to 20 parts by weight of the sulfonic acid salt (B) based on 100 parts by weight of the calcium phosphate particles (A). This provides a calcium phosphate composition that has a time between the addition of a liquid agent to the calcium phosphate composition and the completion of setting in the use at a clinical site and the like, i.e., a setting time which is within an appropriate range and that is high in mechanical strength and good in marginal sealing ability. | 2010-12-23 |
| 20100323023 | COMPOSITION FOR THE TREATMENT OF A DETACHED RETINA AND METHOD OF PRODUCTION THEREOF - The present invention relates to a composition for use in the treatment of a detached retina, comprising a dispersion of nanoparticles in a liquid, wherein the nanoparticles have a specific gravity which is higher than that of the liquid and the individual refractive indices of the nanoparticles and the liquid are substantially similar to one another. The present invention also relates to a composition for use in the treatment of a detached retina, comprising a dispersion of silica nanoparticles in a liquid, a method and kit of parts for producing the compositions and a method of treating a detached retina. | 2010-12-23 |
| 20100323024 | PUUMALA VIRUS FULL-LENGTH M SEGMENT-BASED DNA VACCINES - The invention contemplates a new synthetic, codon-optimized Puumala virus (PUUV) full-length M gene open reading frame (ORF) that encodes a unique consensus amino acid sequence. The PUUV ORF was cloned into a plasmid to form the first stable PUUV full-length M gene that elicits neutralizing antibodies. The gene can be engineered into a molecular vaccine system, and is useful to protect mammals against infection with Puumala virus. | 2010-12-23 |
| 20100323025 | TIMED-RELEASE PHARMACEUTICAL PREPARATION - The timed-release pharmaceutical preparation of the invention is characterized by having a core containing a drug and a water-swellable substance, and a film containing a water-insoluble polymer, a plasticizer, and a water-insoluble filler, the core being coated with the film. | 2010-12-23 |
| 20100323026 | SUSTAINED RELEASE PREPARATION FOR TISSUE REGENERATION THERAPY - The object of the present invention is to provide a microsphere which has a slow-release period of from about two weeks to about four weeks following administration, enables a higher content of a drug to be included, suppresses an initial burst of the drug, and enables the drug to be maintained at an optimal, effective blood concentration during the slow-release period. | 2010-12-23 |
| 20100323027 | MESENCHYMAL STEM CELL CONDITIONED MEDIUM - We disclose a method of preparing a conditioned cell culture medium, the method comprising the steps of: (a) culturing a mesenchymal stem cell (MSC), a descendent thereof or a cell line derived therefrom in a cell culture medium; and (b) optionally isolating the cell culture medium; in which the mesenchymal stem cell (MSC) is obtained by propagating a cell obtained by dispersing a embryonic stem (ES) cell colony, or a descendent thereof, in the absence of co-culture in a serum free medium comprising FGF2. | 2010-12-23 |
| 20100323028 | METHOD AND COMPOSITION FOR TREATING PULMONARY HEMORRHAGE - The invention relates to methods and compositions for treating and preventing pulmonary hemorrhage in an animal, and for reducing red blood cells in the airways of an animal. More particularly, the invention relates to methods and compositions for treating and preventing pulmonary hemorrhage in an animal, and for reducing red blood cells in the airways of an animal wherein a feed composition comprising an about 3:1 to an about 1:3 ratio of docosahexaneoic acid to eicosapentaenoic acid is fed to the animal. | 2010-12-23 |
| 20100323029 | FIVE-COORDINATE NEUROGLOBIN AND USE THEREOF AS A BLOOD SUBSTITUTE - Described herein is the finding that a mutant form of human neuroglobin (H64L) with a stable five-coordinate geometry reduces nitrite to nitric oxide approximately 2000-times faster than the wild type neuroglobin. Five-coordinate neuroglobin is also capable of binding and releasing oxygen. Based on these findings, the use of five-coordinate neuroglobin as a blood substitute is described herein. Particularly provided is a method of replacing blood and/or increasing oxygen delivery to tissues in a subject by administering to the subject a therapeutically effective amount of neuroglobin with a stable five-coordinate geometry. In some cases, five-coordinate neuroglobin is administered in combination with another therapeutic agent or composition, such as a second blood replacement product (for example, a hemoglobin-based oxygen carrier), a blood product (such as red blood cells, serum or plasma) or whole blood. | 2010-12-23 |
| 20100323030 | Composition with Anti-Inflammatory, Protein Synthesizing, Enzyme Deficiency Activating Genetic Therapy and Anti-Cancer Activity and Methods of Use - A composition for treating damaged tissue and promoting healthy tissue growth, healing and tissue regeneration, wherein said composition comprises an extracellular matrix compound, a surface-active lipid, one or more enantioinerically pure L-amino acids or glycine, a hydrophilic surfactant with a high HLB, as well as vitamins, minerals or trace elements. Not only does it maintain good health, but the components are non-intrusive, bio-safe, non-coalescent and can mimic normally occurring stem-cells within a body. When applied to diseased tissues, the subject compositions can stimulate, facilitate, and accelerate protein synthesis for the regeneration of diseased organs and tissues. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system. | 2010-12-23 |
| 20100323031 | Synergistic combination to enhance blood glucose and insulin metabolism - The present disclosure discloses a synergistic combination comprising (−)-hydroxycitric acid, bitter melon extract and sesame seed lignans extract to enhance blood glucose and insulin metabolism. The synergistic combination also reduces reactive hypoglycemia in those who are insulin resistant. | 2010-12-23 |
| 20100323032 | AGENT FOR TREATING ULCER - An agent for treating ulcer containing, as an effective component, a particulate composite hydrotalcite obtained by solidly dissolving a small amount of zinc in the particulate hydrotalcite, exhibiting excellent effect for treating the peptic ulcer and, further, working as a Zn-supplying agent. The agent for treating the ulcer is represented by the following formula (1), | 2010-12-23 |
| 20100323033 | CANCER SENSITIZER COMPRISING CHLOROGENIC ACID - The present invention relates to a cancer sensitizer comprising chlorogenic acid or a derivative thereof. In particular, the present invention relates to a cancer sensitizer comprising chlorogenic acid or a derivative thereof, which can make cancer cells sensitive to anticancer agents to increase the therapeutic effect of anticancer agents. In addition, the present invention relates to a composition for inhibiting the chemo-resistance of cancer cells, comprising chlorogenic acid or a derivative thereof in combination with a pharmaceutically acceptable carrier, an anticancer composition comprising an anticancer agent in addition to the composition, and a method for disrupting the chemo-resistance of cancer cells, comprising administration of the cancer sensitizer. | 2010-12-23 |
| 20100323034 | METHOD FOR DETERMINATION OF SENSITIVITY TO ANTI-CANCER AGENT - Provided are an marker for determining sensitivity to an anticancer agent capable of distinguishing a therapeutic response of an individual patient and a novel means for a cancer therapy using the marker. The marker for determining sensitivity to an anticancer agent contains a calcium-binding protein S100A7, S100A8, or S100A10. | 2010-12-23 |
| 20100323035 | Multifunctional compositions having combined insecticidal, miticidal and fungicidal activity - Particular aspects provide novel insecticide/miticide/fungicide compositions, and methods for using same for safe, environmentally friendly control of insects, mites and fungal pests in, e.g., gardening and commercial growing. Preferably, the compositions comprise organic or pure ingredients. Particular embodiments comprise: a fatty acid soap base (e.g., saponified soap with retained glycerin; or fatty acid salts with glycerin); at least one essential oil; an optional food oil; and a bicarbonate reagent, along with water. Additional embodiments comprise: a soap base, and/or glycerin or other suitable base; at least one organic or pure plant essential oil; an organic or pure food oil; and a bicarbonate reagent, along with water as diluent and carrier, and methods for using same. Further aspects provide a method for controlling mite and fungal pests with a single composition comprising, along with an aqueous carrier or diluent: a non-petroleum-based food oil; and a bicarbonate agent. | 2010-12-23 |
| 20100323036 | Nitric Oxide Therapies - A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition. | 2010-12-23 |
| 20100323037 | ANTIMICROBIAL COMPOSITION - A composition that includes ethylhexyl sulfate or a salt thereof, an alkylbenzenesulfonic acid or a salt thereof, and a carrier. The ethylhexyl sulfate, or salt thereof, and the alkylbenzenesulfonic acid, or salt thereof, are present in a weight ratio of at least about 1:2. The composition can be used for killing or inhibiting a microorganism or pathogen (e.g., bacteria, gram-negative bacteria, gram-positive bacteria, enteric bacteria, virus, fungus, mold, mildew or powdery mildew). | 2010-12-23 |
| 20100323038 | Pharmaceutical Compositions - The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects. | 2010-12-23 |
| 20100323039 | LABISIA PUMILA EXTRACTS FOR REDUCING THE RISK OF CARDIOVASCULAR DISEASES - There is disclosed a standardised aqueous extract of | 2010-12-23 |
| 20100323040 | COSMETIC COMPOSITION FOR TOPICAL USE COMPRISING WASABI - The present invention relates to a cosmetic composition comprising an extract of wasabi, and a cosmetically acceptable carrier. | 2010-12-23 |
| 20100323041 | METHODS AND THERAPEUTIC COMPOSITIONS COMPRISING PLANT EXTRACTS FOR THE TREATMENT OF CANCER - A method of treating cancer by targeting two proteases, MMP-9 and cathepsin B is provided. Therapeutic compositions comprising one or more plant extracts that inhibit MMP-9 and/or cathepsin B, which are capable of inhibiting neoplastic and/or endothelial cell migration, tumor growth, tumor-induced angiogenesis and/or metastasis are also provided. The therapeutic compositions of the invention can be used in the treatment of cancer, and methods of inhibiting tumor growth, tumor metastasis, and/or tumor-induced angiogenesis using the therapeutic compositions alone or in combination with an anti-cancer agent are, therefore, also provided. | 2010-12-23 |
| 20100323042 | Methods And Compositions For Treating Skin - A method for formulating products to normalize skin or treat irritated or inflamed skin, a method for normalizing skin or treating irritated or inflamed skin for improvement, and compositions therefor. | 2010-12-23 |
| 20100323043 | Antimicrobial Compositions and Methods of Making and Using the Same - Antimicrobial (e.g., moldicide, fungicide, and bacteriacide) compositions are disclosed. Methods of making and using antimicrobial (e.g., moldicide, fungicide, and bacteriacide) compositions are also disclosed. | 2010-12-23 |
| 20100323044 | ABNORMAL PROTEIN REMOVING METHOD - A method for suppressing dull complexion or wrinkles or providing moisture-keeping effect in skin of a subject by removing abnormal protein includes administering to the subject desiring such suppression and moisture-keeping effect a food composition containing a soybean extract containing 40 to 100 parts by weight of soyasaponin B group relative to 100 parts by weight of the soybean extract in an effective amount. | 2010-12-23 |
| 20100323045 | EXTRACT FORMULATION OF OPUNTIA FICUS INDICA - A process for the preparation of an | 2010-12-23 |
| 20100323046 | NOVEL USES OF HIBISCUS, IN PARTICULAR PHARMACEUTICAL USES - The invention relates to the use of | 2010-12-23 |
| 20100323047 | Solid one-piece cutter hub and blade combination - A cutter hub for an underfluid pelletizer in which pelletizable material such as molten polymer is extruded as strands through orifices in a die plate. The cutter hub has a plurality of cutter blades integral therewith and is made of a single solid one-piece construction of hub and blades. The cutter hub is rotatably driven and moves along the face of the die plate so that the blades cut the extruded strands into pellets. The cutter hub preferably includes self-aligning structure. | 2010-12-23 |
| 20100323048 | CUFF FOR USE WITH MEDICAL TUBING AND METHOD AND APARATUS FOR MAKING THE SAME - A method of manufacturing more than one inflatable cuff per blow molding operation is provided. The method includes using two or more molds arranged in series and/or in parallel to simultaneously form two or more cuffs. The two or more cuffs may then be used in the manufacture of two or more respective endotracheal tubes. Apparatuses and systems for simultaneously forming the two or more cuffs are also provided. | 2010-12-23 |
| 20100323049 | Adjustment mechanism for extrusion die - A device is constructed for adjusting the concentricity of a die within an extrusion die assembly. The adjustment mechanism involves a series of compound screws having multiple operating threads that employ different pitches to generate a fine adjustment motion. The compound screws are coupled to opposing spring loaded plungers that move against a bias spring in reaction to movement of the compound screws. | 2010-12-23 |
| 20100323050 | THREE-DIMENSIONAL OBJECT FORMING APPARATUS AND METHOD FOR FORMING THREE DIMENSIONAL OBJECT - A three-dimensional object forming apparatus forms a three-dimensional object by binding powder particles with a curable liquid. The apparatus includes a powder layer forming unit that spreads a powder to a uniform thickness to form a powder layer. A curable liquid ejection head ejects the curable liquid to the powder layer through an ejection nozzle. A sectional data producing device produces sectional data at each of a plurality of cross sections of a desired three-dimensional object according to shape data of the desired three-dimensional object. A cross-sectional member forming section is also included by which cross-sectional members are formed by ejecting the curable liquid to the powder layer from the curable liquid ejection head according to the sectional data and thus binding the powder layer. The cross-sectional member forming section includes a permeation rate controller controlling the permeation rate of the curable liquid to the powder layer. | 2010-12-23 |
| 20100323051 | Lock for core assembly for injection molding tool - An injection molding tool having a core assembly with a shaft that is lockably or securedly mounted within a bore of a plate or within another suitable lock element. Rotational or other suitable movement of the lock results in or translates into axial movement of and/or axial forces apply to the core assembly. A guide ring assembly has a center ring with a non-circular bore and a correspondingly shaped core assembly, to prevent rotational movement of the core assembly with respect to the guide ring assembly. | 2010-12-23 |
| 20100323052 | NEEDLE-TO-NEEDLE ELECTROSPINNING - The disclosure relates to a method and apparatus for coating a medical device. The method includes providing an electrospinning apparatus and simultaneously electrospinning at least one solution onto a first surface and an opposing second surface. The apparatus comprises a first spinneret and a second spinneret. An energy source is electrically coupled to the first spinneret and the second spinneret. The first spinneret and second spinneret comprise a reservoir and an orifice fluidly coupled to the reservoir. The first spinneret orifice is located substantially opposite the second spinneret orifice. | 2010-12-23 |
| 20100323053 | Roller Type Electrostatic Spinning Apparatus - A roller type electrostatic spinning apparatus is disclosed, which includes an electrostatic spinning solution impregnation mechanism having a sizing roller, a linear emitting electrode disposed on the sizing roller, a collecting electrode module, and a high-voltage power supply. The collecting electrode module includes a casing, several exhaust vent disposed on the casing, several slits disposed on the casing, and several serrate collecting electrodes disposed next to the slits. The high-voltage power supply is connected to the linear emitting electrode and the serrate collecting electrodes. | 2010-12-23 |
| 20100323054 | External plate locks for mold plates - A locking device for a mold including more than one movable plate. A spring-biased wedge block includes a first side wall and an opposing second side wall that is beveled with respect to the first side wall. A latch bar includes an inclined latch end for engaging with the second side wall of the wedge block. A cam bar includes a cam end for engaging with the first side wall of the wedge block. At least one of the wedge block, the latch bar or the cam bar is formed of a 4340 steel alloy, and at least one of the latch end, the cam end, or the wedge block second side wall is nitrided or nitride coated. | 2010-12-23 |
| 20100323055 | GOLF BALL AND GOLF BALL MOLD - The invention provides a golf ball manufactured using a mold having a top half and a bottom half, which ball has formed on a surface thereof, near a seam line corresponding to a parting line between the top and bottom halves of the mold, a recessed and/or raised mark serving as an indicator for detecting the direction or position of the seam line. The invention also provides a golf ball mold composed of a top half and a bottom half that detachably join together so as to form therein a spherical cavity into which a material is injected to mold a golf ball, which mold bears, near a parting line between the top and bottom halves on a wall of the cavity, a raised or recessed feature for forming a mark as an indicator for detecting the direction or position of the parting line. The invention enables the direction and position of the seam line on the surface of the ball to be easily identified and enables the subsequent steps of visually inspecting the ball and applying indicia to the surface of the ball to be carried out more smoothly and advantageously, making it possible in particular to greatly shorten the time devoted to these operations. | 2010-12-23 |
| 20100323056 | CROSS-LINKED THERMOPLASTIC POLYURETHANE/POLYUREA AND METHOD OF MAKING SAME - A process for forming a cross-linked thermoplastic polymer is disclosed herein. The cross-linked thermoplastic polymer is formed by heating a first mixture containing a thermoplastic urethane base material, a monomeric diisocyanate comprising between 1 to 10% of the total weight of the first mixture, and a second mixture of a first diamine and a second diamine comprising between 1 to 10% of the total weight of a total reaction product. The heated first mixture, which is flowable, is injected into at least one injection molding device, with the second mixture injected at predetermined intervals to create a homogeneous reaction product. | 2010-12-23 |
| 20100323057 | SCREW AND INJECTION APPARATUS - An object is to reduce the axial dimension of an injection apparatus, melt a molding material uniformly, and improve the quality of molded products. A screw ( | 2010-12-23 |
| 20100323058 | METHOD FOR PRODUCING FISH PASTE PRODUCT, AND ENZYME PREPARATION FOR FISH PASTE PRODUCTS - In the process of producing a fish paste product, adding a defined amount of a transglutaminase and ascorbic acid or a related compound thereof are added to material surimi can suppress changes in the physical properties of nerimi during the process of producing a fish paste product and a fish paste product having a preferable firmness and elasticity can be obtained even in the case of reducing the amount of material surimi. | 2010-12-23 |
| 20100323059 | BREWING APPARATUS AND METHOD - The specification discloses brewing apparatus and a method for testing for end of fermentation of a fermenting brew. It has been determined that, once fermentation is complete, the temperature of a brew (such as beer) shows a tendency to stratify in horizontal layers. However, the activity of fermentation disrupts the tendency of the brew to stratify. Accordingly, the brewing apparatus comprises at least two temperature sensors positioned to measure a temperature difference between the temperature at a first height of the brew and the temperature at a second height of the brew. End of fermentation is identified if the temperature difference is greater than a threshold difference. | 2010-12-23 |
| 20100323060 | Method of, and Apparatus for, Flavor Recovery in Beer Brewing - A beer-brewing method, and an apparatus implementing the method, where vapors escaping from the wort during a boiling phase are passed, on the steam side, to a rectifying column connected to a wort boiler and the vapors are rectified, at least one flavor-containing distillate being recovered from the vapors and being fed to the wort following the boiling phase. | 2010-12-23 |
| 20100323061 | ENZYMES FOR STARCH PROCESSING - The present invention relates to a hybrid enzyme comprising carbohydrate-binding module amino acid sequence and a fungal alpha-amylase amino acid sequence and to a variant of a fungal wild type enzyme comprising a carbohydrate-binding module and an alpha-amylase catalytic module. The invention also relates to the use of the hybrid enzyme or the variant in starch liquefaction. | 2010-12-23 |
| 20100323062 | BIOPROCESSING OF GRAINS - A method of treating a crop kernel prior to milling to improve millability, which includes the step of exposing the crop kernel to one or more plant hormones is provided. Typically, the crap kernel is a cereal such as wheat. The plant hormone is selected from the group consisting of auxins, gibberellins and abscisic acid. The method further includes the step of exposing the crop kernel to an enzyme. Typically the enzyme is a plant cell-wall degrading enzyme such as xylanase, lipase and cellulase. Also provided are methods of production of flour, food products and compositions. A particular application of this method is the optimisation of milling performance for the production of high quality flour. | 2010-12-23 |
| 20100323063 | PROCESS FOR THE PREPARATION OF ISOMALTOOLIGOSACCHARIDE-HYDROGENATED - Processes for preparing isomaltooligosaccharide-hydrogenated (‘IMO-H’) syrup and IMO-H syrup made by the processes. In the process isomaltooligosaccharide (‘IMO’) is generally obtained by liquefying a raw material and then conducting one or more saccharification steps followed by additional processing steps, including filtration, decolorization, ion-exchange and evaporation. The IMO is then hydrogenated and the IMO-H is refined. | 2010-12-23 |
| 20100323064 | Agent For Improving Viability of Lactic Acid Bacteria - An object of the present invention is to provide a novel agent for improving the viability of lactic acid bacteria, which has an excellent effect on the improvement of the viability of lactic acid bacteria in the product, has no adverse effect on the flavor of the product and requires less production cost. An agent for improving the viability of lactic acid bacteria characterized by using manganese as an effective ingredient. A manganese-containing material may be used as manganese. Manganese is preferably formulated at 5 μg/100 g or more in the final product. | 2010-12-23 |
| 20100323065 | Beverage Preservative System Containing Pimaricin-Cyclodextrin Complex - The present invention provides a beverage preservative system comprising a pimaricin-cyclodextrin complex for use in beverages products. The present invention is further directed to beverage products comprising the beverage preservative systems. The beverage preservative system prevents spoilage by microorganisms in a beverage within a sealed container for a period of at least 16 weeks. | 2010-12-23 |
| 20100323066 | Process for Solubilization of Flavor Oils - The inventive process allows the solubilization of flavor oil in water to produce clear beverages. The amount of emulsifier required for oil solubilization is less than that of oil, and a typical oil to emulsifier ratio is 2:1. A crude emulsion is first generated by high shear mixing of the emulsifier solution and flavor oil. The crude emulsion is then fed into a homogenizer to produce a finer emulsion. The resulting flavor concentrate can then be diluted to produce clear beverages. This process also simplifies the introduction of normally insoluble nutraceuticals, particularly lipophilic ones, into beverages. Compared to microemulsion formulations, this process provides an easy way of formulation customization to different flavors and nutraceuticals. | 2010-12-23 |
| 20100323067 | TEMPERATURE RESISTANT CHOCOLATE COMPOSITION AND METHOD - A chocolate composition and a method for manufacturing the chocolate composition include a solid material, e.g., nutritive carbohydrate sweetener that has a particle size from about 50 to about 1000 nanometers. The solid material may comprise a sugar, such as but not limited to, sucrose. By including within the chocolate composition the solid material that has the particle size from about 50 to about 1000 nanometers, the chocolate composition has enhanced temperature resistance properties. | 2010-12-23 |
| 20100323068 | COLD WATER SOLUBILITY OF POWDERS - The present invention relates to powders, preferably milk-based powders, in particular instant drink powders which have improved cold water solubility. It further relates to capsules comprising said powders and to a method of preparing a cold instant drinks. | 2010-12-23 |
| 20100323069 | HIGH-TEMPERATURE PACKAGING OF BONE IN MEAT PRODUCT - Methods and apparatuses for preparing a ribbed meat product in a reduced cook cycle. The methods may comprise placing a ribbed meat product into a high-temperature cook-in bag suitable for high-temperature cooking processes that occur at temperatures greater than about 350° F. and sealing the high-temperature cook-in bag to create a package. The high-temperature cook-in bag containing the ribbed meat product may be placed directly into an oven and exposed to a temperature greater than about 350° F., reducing the cook time necessary to render or rethermalize the ribbed meat product by a factor of about 3 as compared to conventional low temperature cooking processes. The benefits of the disclosed methods include reduced cook times to render or rethermalize ribbed meat products, enhanced flavor of the ribbed meat products, reduced risk of contamination, and improved cleanliness. Both cooked and uncooked ribbed meat products may be prepared in these methods. | 2010-12-23 |
| 20100323070 | INSTANT-PREPARED FRIED NOODLE AND PRODUCING METHOD OF THE NOODLE - The present invention directed to instant-prepared fried noodle and aimed to reduce an amount of fats and oils therein and realize those with favorable texture and taste with the simple method without depending on any special device. Dough is prepared by adding 0.3-0.6 weight by percent in total of sodium carbonate and/or potassium carbonate to raw noodle flour like wheat flour, then adding edible acid substance thereto to adjust dough pH to 7.5-8.5, and kneading them with brine water. The dough so produced is rolled, cut, steamed, then seasoning solution or water is absorbed into noodle strings so made and the noodle strings are dried by frying them with oil of 130° C.-160° C. Thereby, an amount of fats and oils in the instant-prepared fried noodle bricks can be reduced without generating any scorching damage in the noodle strings. | 2010-12-23 |
| 20100323071 | INTEGRATED MIXING AND CLEANING BEVERAGE ASSEMBLY AND METHOD THEREOF - An integrated beverage dispensing and cleaning system comprising: at least one blender module which blends and/or mixes ice, at least one other ingredient, and/or at least one mixin within a beverage container, thereby producing the beverage; and a cleaning assembly integrated with the blender module, wherein, upon removal of the beverage container from the blender module, a cleaning mode is initiated. | 2010-12-23 |
| 20100323072 | ANTIMICROBIAL TREATMENT SYSTEM AND METHOD FOR FOOD PROCESSING - A system and method for reducing microbial populations on food products in a food processing facility. One embodiment provides a combination of interventions including a liquid antimicrobial treatment station that wets a food product with an antimicrobial solution containing at least one antimicrobial agent and a gaseous antimicrobial treatment station that generates and exposes the wetted food product to advanced oxidative gaseous environment. A transport system is provided for transporting the food product between the first and second treatment stations. In one embodiment, the advanced oxidative gases may be generated by plurality of photohydroionization cells. In one embodiment, the system and method may be used in a meat processing facility. | 2010-12-23 |
| 20100323073 | FRESHWATER DIATOMACEOUS EARTH PRODUCTS CONTAINING REDUCED SOLUBLE METAL LEVELS, PROCESSES FOR REDUCING SOLUBLE METAL LEVELS IN FRESHWATER DIATOMACEOUS EARTH PRODUCTS, AND METHODS OF USING THE SAME - Disclosed herein are freshwater diatomaceous earth products containing reduced soluble metal levels, processes for reducing soluble metal levels in freshwater diatomaceous earth products, and methods of using the same. In particular, freshwater diatomaceous earth products are disclosed that have been treated with at least one surface metal blocking agent, such as an organic silicone compound with at least one functional group capable of forming a chelating complex with metal ions, to reduce the level of soluble metals associated therewith. Such freshwater diatomaceous earth products containing reduced soluble metal levels may be useful for various applications including as filter aid materials. | 2010-12-23 |
| 20100323074 | DEVICE FOR HEATING AND FOAMING MILK - A device for heating and foaming milk includes a steam-generating device to generate steam by heating water. The steam generating device has a steam outlet. A shut-off value is coupled to the steam outlet. A first line is coupled via the shut-off valve to the steam outlet of the steam-generating device so that steam can be discharged through the first line from the steam-generating device. The first line is selectively opened and closed with the aid of the shutoff valve. The first line has an outlet arranged to be submerged directly into a container which contains the milk to be foamed. A second line having an outlet is coupled to a pump to pump air into the second line. The outlet of the second line is arranged to be submerged separately and at a distance to the first line directly into the container holding the milk to be foamed, so that steam and air is supplied completely separate from each other during the heating and foaming of the milk. | 2010-12-23 |
| 20100323075 | PROCESS FOR PRODUCING SOYMILK AND APPARATUS FOR PRODUCING SOYMILK - [Task] High-quality soymilk is produced, with overflow of foam or bubbles avoided in an extracting step, and the extractability (extraction ratio) of the soymilk is simultaneously heightened. | 2010-12-23 |
| 20100323076 | Method For Reversing An Oxidized Off-Flavor From Milk - A method of reversing the formation of an oxidized off-flavor in milk that includes providing milk, and heating the milk to a temperature between approximately 70° C. and approximately 90° C. for a period of between approximately 25 seconds and approximately 60 seconds. | 2010-12-23 |
| 20100323077 | FOOD SUBSTANCE FLIPPING SYSTEM, METHOD AND APPARATUS - A food substance flipping apparatus including a handle support member fixedly attached to a handle of the flipping apparatus and an outer support member coupled to the handle support member disposable to engage the food substance. | 2010-12-23 |
| 20100323078 | SHELF STABLE LIQUID WHITENER AND PROCESS OF MAKING THEREOF - A shelf-stable, liquid whitening composition having a whitening agent and a stabilizing system are disclosed. The stabilizing system includes a gum component, preferably of a mixture of two different gum, present in an amount sufficient to suspend the whitening agent in the liquid whitening composition and in an aqueous media to which the liquid whitening composition is added, an emulsifier in an amount sufficient to maintain emulsion stability in the liquid whitening composition and in the aqueous media, and a cellulose component, preferably of a blend of a microcrystalline cellulose and carboxymethylcellulose blend, in an amount sufficient to help maintain suspension and emulsion stability of the liquid whitening composition alone and in the aqueous media. The stabilizing system maintains the liquid whitener in a homogeneous state for at least about 9 months at ambient temperatures, and further maintains the whitening composition in suspension when added to the aqueous media. | 2010-12-23 |
| 20100323079 | OILY FOOD AND METHOD FOR PRODUCING THE SAME - An object of the invention is to develop an oily food which has low viscosity relative to the oil content, (that is, if the viscosity is comparable, the food has a lower oil content and thus has a lower calorie, and if the oil content is comparable, the food has a lower viscosity), excellent taste, physical property and coating aptitude by an inexpensive and simple method and a method for producing the same. The present inventors made intensive studies for achieving the above object. As a result, a low-oil content and low-calorie oily food which can exhibit a lower viscosity if the oil content is comparable, and can achieve a lower oil content if the viscosity is comparable as compared with a conventional oily food material, has good texture and flavor, and can be variously applied can be produced by a simple method by subjecting dough after undergoing a refining step to conching at a lower oil content than conventional, preferably at a lower temperature thereby to change a dry state to a liquid state, that is, by performing conching in a state of a low fluidity thereby to apply high shear and to discharge oil and fat which is incorporated in tissue and does not contribute to the fluidity outside the tissue. | 2010-12-23 |
| 20100323080 | FOOD COMPOSITIONS FOR SALTING IN PARTICULAR - The application relates, in particular, to a salting composition comprising at least two potassium salts at least one of which is a potassium organic salt. The application likewise relates to a method of preparing a food product comprising at least one step consisting of adding said composition to a food product. Finally, the application also relates to the use of said composition as a salting agent. | 2010-12-23 |
| 20100323081 | FLAVOR IMPROVING AGENT - The present invention relates to a method of producing a flavor improving agent, comprising heating amino acids or peptides in the presence of amino sugars or a method of improving the flavor of a food or drink with the use of the flavor improving agent. Preferably, the method of improving flavor involves the enhancement of stewed taste of a stewed food or drink. In addition, the present invention relates to a method of producing a stewed food or drink, comprising a step of adding amino sugars to a food or drink material containing amino acids or peptides followed by heat cooking. Examples of amino sugars are glucosamine and galactosamine. | 2010-12-23 |
| 20100323082 | PROCESSED AND ROASTED COFFEE BEAN AND METHOD FOR PRODUCTION OF PROCESSED AND ROASTED COFFEE BEAN - The present invention provides refined roasted coffee beans having a Hunter L value of 10 to 30 and a hydroxyhydroquinone content of not higher than 30 mg/kg by contacting an aqueous solvent with raw material roasted coffee beans. The invention also provides a process for producing refined roasted coffee beans, which includes contacting raw material roasted coffee beans having a Hunter L value of 12 to 35, with coffee bean-derived extract-containing water selected from water containing an extract derived from roasted coffee beans having a Hunter L value of 40 or more and water containing an extract derived from raw coffee beans. | 2010-12-23 |
| 20100323083 | METHOD FOR COMPACTING PLANT POWDERS AND PRODUCTS OBTAINED THEREFROM - The present invention relates to tablets allowing hot drinks to be prepared by lixiviation and especially coffee. It also relates to the preparation method by which said tablets may be made. | 2010-12-23 |
| 20100323084 | FAT AND OIL COMPOSITIONS FOR IMPROVING TEXTURE - The present invention discloses a fat and oil composition which comprises 25-60 mass % of a soft fractionated palm oil, a polyglycerol ester of fatty acids and a cooking oil other than palm oil, | 2010-12-23 |
| 20100323085 | FATTY ACID COMPOSITIONS HAVING NOVEL FATTY ACID RATE - The object of the present invention is to provide a fatty acid composition whose fatty acid rate differs from that previously reported. | 2010-12-23 |
| 20100323086 | PLANTS AND SEEDS OF SPRING CANOLA VARIETY SCV218328 - The invention relates to a novel canola line designated as SCV218328. The invention also relates to the seeds, the plants, and the plant parts of canola line SCV218328 as well as to methods for producing a canola plant produced by crossing canola line SCV218328 with itself or with another canola line. The invention also relates to methods for producing a canola plant containing in its genetic material one or more transgenes and to the transgenic canola plants and plant parts produced by those methods. The invention further relates to canola lines or breeding lines and plant parts derived from canola line SCV218328, to methods for producing other canola lines or plant parts derived from canola line SCV218328 and to the canola plants, varieties, and their parts derived from use of those methods. The invention additionally relates to hybrid canola seeds, plants, and plant parts produced by crossing the line SCV218328 with another canola line. | 2010-12-23 |
| 20100323087 | Method for producing quick-cooking rice and quick-cooking rice produced by the method - Raw material rice (brown rice and partially-milled rice) is subjected to a preliminary pressurized steam-boiling process to form an alpharized layer on the surface of the raw material rice, and then a moisture adding process is performed. Since the surface of the raw material rice is alpharized to become stiff with the preliminary pressurized steam-boiling process, even rapid moisture addition does not cause a crack in the raw material rice. Therefore, water absorption can be quickly achieved to a target moisture content, thereby reducing a moisture adding time. Also, with no crack, quick-cooking rice with an excellent outer appearance of rice as a product and without a drain of nutrients in rice grains at the time of rice cooking. | 2010-12-23 |
| 20100323088 | RECOMBINED WHOLE GRAIN WHEAT HAVING VISUALLY INDISTINGUISHABLE PARTICULATE MATTER AND RELATED BAKED PRODUCTS - A recombined whole grain flour for use in preparing whole grain products such that whole grain particulates provide minimal visual impact to the whole grain product. By selectively controlling the particle size of the milled bran and germ constituents used in the recombined whole grain flour, the visual and color impact associated with bran and germ particulates can be substantially eliminated from the whole grain product. In particular, whole grain products such as whole grain breads, dough products, mixes and biscuits can be made with recombined whole grain flour. Whole grain products made with recombined whole grain flour are advantageous in that they incorporate the health advantages associated with whole grains while eliminating the characteristic, visual color differences noticeable within a whole grain crumb due to visually identifiable bran and germ particulates found in traditional whole grain products. | 2010-12-23 |
| 20100323089 | PROCESS FOR PRODUCING A SPICY MIXTURE AND ALSO USE OF THE SPICY MIXTURE - A process for preparing a spicy mixture based on buckwheat is described, comprising preparing shelled buckwheat kernels and heating the buckwheat kernels to obtain preroasted buckwheat kernels; adding edible oil to the preroasted buckwheat kernels while continuing the roasting so that the edible oil is added to the preroasted buckwheat kernels in an amount sufficient that the surface of the buckwheat kernels are completely wetted by the edible oil, and continuing the roasting until the buckwheat kernels develop a golden-yellow coloration due to absorption of oil and the roasting; spraying a solution containing salt, sugar or at least one flavoring to the oil and roasted buckwheat kernels so that the oiled and roasted buckwheat kernels are wetted at the surface with the solution containing the salt, sugar or flavoring; and continuing the roasting until providing the spicy mixture as solvent-free roasted buckwheat kernels containing salt, sugar or flavoring. | 2010-12-23 |
| 20100323090 | METHOD FOR PRODUCTION OF ORALLY RAPIDLY DISINTEGRATING TABLET COMPRISING IMIDAFENACIN AS ACTIVE INGREDIENT - The present invention herein provides an imidafenacin-containing orally rapidly disintegrating tablet which is excellent in the photostability. | 2010-12-23 |
| 20100323091 | Methods To Increase Fracture Resistance Of A Drug-Eluting Medical Device - Methods for increasing the fracture resistance of a polymer stent's drug-polymer coating and scaffolding including applying a coating and crimping using techniques that increase the resistance to fracture in the coating layer and scaffolding and scaffolding. | 2010-12-23 |
| 20100323092 | Stent Coating Device - The present invention is a method and device, which is suitable for use in an operating theater just prior to implantation, for selectively applying a medical coating to an implantable medical device, for example a stent. Disclosed is a device for use with a stent deployed on a catheter balloon. The device is configured to apply a medical coating of a desired thickness to the surface of a stent only. This is done by use of a drop-on-demand ink-jet printing system in association with an optical scanning device. The device is further configured so as to, if necessary, apply a plurality of layered coats, each layered coat being of a different coating material, and if appropriate, different thickness. The section of the housing in which the stent is held during the coating procedure is detachable from the housing base. The detachable housing section may be easily cleaned and re-sterilized or simply disposed of. | 2010-12-23 |
| 20100323093 | Method of Drying Bioabsorbable Coating Over Stents - Various embodiments of methods for coating stents are described herein. Applying a composition including polymer component and solvent to a stent substrate followed by exposing the polymer component to a temperature equal to or greater than a Tg of the polymer component is disclosed. Repeating the applying and exposing one or more times to form a coating with the result that the solvent content of the coating after the final exposing step is at a level suitable for a finished stent is further disclosed. | 2010-12-23 |
| 20100323094 | POROUS BIOMATERIALS SURFACE ACTIVATION METHOD - The present invention relates to a porous biomaterials surface activation method by coating with a layer of apatitic nanocrystals in order to increase their surface reactivity. The method according to the invention is characterized by the following steps:
| 2010-12-23 |
| 20100323095 | METHOD FOR THE HARDENED GALVANIZATION OF A STEEL STRIP - A method produces a hardened galvanization of a continuously-running rolled steel strip. The strip is immersed in a coating tank containing a bath of a liquid metal mixture, e.g. zinc and aluminum, to be deposited on the strip, and permanently circulated between the coating tank and a preparation device. The temperature of the liquid mixture is deliberately lowered in order to reduce the iron solubility threshold and sufficiently high for initiating, in the preparation device, the fusion of at least one Zn—Al ingot in an amount necessary for compensating for the liquid mixture used for deposition on the strip. The device is implemented so that the circuit for circulating the liquid mixture is thermally optimized. | 2010-12-23 |
